These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Real-world effectiveness of antidepressants, antipsychotics and their combinations in the maintenance treatment of psychotic depression. Evidence from within-subject analyses of two nationwide cohorts. Taipale H; Lieslehto J; Lähteenvuo M; Hamina A; Tanskanen A; Mittendorfer-Rutz E; Paljärvi T; Solmi M; Cipriani A; Correll CU; Tiihonen J World Psychiatry; 2024 Jun; 23(2):276-284. PubMed ID: 38727044 [TBL] [Abstract][Full Text] [Related]
3. Association of Pharmacological Treatments and Hospitalization and Death in Individuals With Amphetamine Use Disorders in a Swedish Nationwide Cohort of 13 965 Patients. Hartikainen M; Taipale H; Tanskanen A; Mittendorfer-Rutz E; Lähteenvuo M; Tiihonen J JAMA Psychiatry; 2023 Jan; 80(1):31-39. PubMed ID: 36383348 [TBL] [Abstract][Full Text] [Related]
4. Comparative Effectiveness of Antipsychotics in Patients With Schizophrenia Spectrum Disorder. Hamina A; Taipale H; Lieslehto J; Lähteenvuo M; Tanskanen A; Mittendorfer-Rutz E; Tiihonen J JAMA Netw Open; 2024 Oct; 7(10):e2438358. PubMed ID: 39382894 [TBL] [Abstract][Full Text] [Related]
5. Comparative effectiveness of mood stabilizers and antipsychotics in the prevention of hospitalization after lithium discontinuation in bipolar disorder. Holm M; Tanskanen A; Lähteenvuo M; Tiihonen J; Taipale H Eur Neuropsychopharmacol; 2022 Aug; 61():36-42. PubMed ID: 35763976 [TBL] [Abstract][Full Text] [Related]
6. Representation and Outcomes of Individuals With Schizophrenia Seen in Everyday Practice Who Are Ineligible for Randomized Clinical Trials. Taipale H; Schneider-Thoma J; Pinzón-Espinosa J; Radua J; Efthimiou O; Vinkers CH; Mittendorfer-Rutz E; Cardoner N; Pintor L; Tanskanen A; Tomlinson A; Fusar-Poli P; Cipriani A; Vieta E; Leucht S; Tiihonen J; Luykx JJ JAMA Psychiatry; 2022 Mar; 79(3):210-218. PubMed ID: 35080618 [TBL] [Abstract][Full Text] [Related]
7. Real-world Effectiveness of Pharmacologic Treatments for the Prevention of Rehospitalization in a Finnish Nationwide Cohort of Patients With Bipolar Disorder. Lähteenvuo M; Tanskanen A; Taipale H; Hoti F; Vattulainen P; Vieta E; Tiihonen J JAMA Psychiatry; 2018 Apr; 75(4):347-355. PubMed ID: 29490359 [TBL] [Abstract][Full Text] [Related]
8. Association of pharmacological treatments and real-world outcomes in borderline personality disorder. Lieslehto J; Tiihonen J; Lähteenvuo M; Mittendorfer-Rutz E; Tanskanen A; Taipale H Acta Psychiatr Scand; 2023 Jun; 147(6):603-613. PubMed ID: 37094828 [TBL] [Abstract][Full Text] [Related]
9. Development and Validation of a Machine Learning-Based Model of Mortality Risk in First-Episode Psychosis. Lieslehto J; Tiihonen J; Lähteenvuo M; Leucht S; Correll CU; Mittendorfer-Rutz E; Tanskanen A; Taipale H JAMA Netw Open; 2024 Mar; 7(3):e240640. PubMed ID: 38497965 [TBL] [Abstract][Full Text] [Related]
10. Pneumonia Risk, Antipsychotic Dosing, and Anticholinergic Burden in Schizophrenia. Luykx JJ; Correll CU; Manu P; Tanskanen A; Hasan A; Tiihonen J; Taipale H JAMA Psychiatry; 2024 Oct; 81(10):967-975. PubMed ID: 38922592 [TBL] [Abstract][Full Text] [Related]
11. Effectiveness of pharmacotherapies for delusional disorder in a Swedish national cohort of 9076 patients. Lähteenvuo M; Taipale H; Tanskanen A; Mittendorfer-Rutz E; Tiihonen J Schizophr Res; 2021 Feb; 228():367-372. PubMed ID: 33548837 [TBL] [Abstract][Full Text] [Related]
19. Antipsychotic Use and Psychiatric Hospitalization in First-Episode Non-affective Psychosis and Cannabis Use Disorder: A Swedish Nationwide Cohort Study. Denissoff A; Taipale H; Tiihonen J; Di Forti M; Mittendorfer-Rutz E; Tanskanen A; Mustonen A; Niemelä S Schizophr Bull; 2024 Nov; 50(6):1287-1294. PubMed ID: 38534050 [TBL] [Abstract][Full Text] [Related]
20. Comparative Effectiveness of Antipsychotic Drugs for Rehospitalization in Schizophrenia-A Nationwide Study With 20-Year Follow-up. Taipale H; Mehtälä J; Tanskanen A; Tiihonen J Schizophr Bull; 2018 Oct; 44(6):1381-1387. PubMed ID: 29272458 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]